Abstract

To understand the mechanisms by which 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE) activates signal transducer and activator of transcription 3 (STAT3), we studied the role of epidermal growth factor receptor (EGFR). 15(S)-HETE stimulated tyrosine phosphorylation of EGFR in a time-dependent manner in vascular smooth muscle cells (VSMCs). Interference with EGFR activation blocked 15(S)-HETE-induced Src and STAT3 tyrosine phosphorylation, monocyte chemoattractant protein-1 (MCP-1) expression and VSMC migration. 15(S)-HETE also induced tyrosine phosphorylation of Janus kinase 2 (Jak2) in VSMCs, and its inhibition substantially reduced STAT3 phosphorylation, MCP-1 expression, and VSMC migration. In addition, Src formed a complex with EGFR and Jak2, and its inhibition completely blocked Jak2 and STAT3 phosphorylation, MCP-1 expression, and VSMC migration. 15(S)-HETE induced the production of H(2)O(2) via an NADPH oxidase-dependent manner and its scavengers, N-acetyl cysteine (NAC) and catalase suppressed 15(S)-HETE-stimulated EGFR, Src, Jak2, and STAT3 phosphorylation and MCP-1 expression. Balloon injury (BI) induced EGFR, Src, Jak2, and STAT3 phosphorylation, and inhibition of these signaling molecules attenuated BI-induced MCP-1 expression and smooth muscle cell migration from the medial to the luminal surface resulting in reduced neointima formation. In addition, inhibition of EGFR blocked BI-induced Src, Jak2, and STAT3 phosphorylation. Similarly, interference with Src activation suppressed BI-induced Jak2 and STAT3 phosphorylation. Furthermore, adenovirus-mediated expression of dnJak2 also blocked BI-induced STAT3 phosphorylation. Consistent with the effects of 15(S)-HETE on the activation of EGFR-Src-Jak2-STAT3 signaling in VSMCs in vitro, adenovirus-mediated expression of 15-lipoxygenase 1 (15-Lox1) enhanced BI-induced EGFR, Src, Jak2, and STAT3 phosphorylation leading to enhanced MCP-1 expression in vivo. Blockade of Src or Jak2 suppressed BI-induced 15-Lox1-enhanced STAT3 phosphorylation, MCP-1 expression, and neointima formation. In addition, whereas dominant negative Src blocked BI-induced 15-Lox1-enhanced Jak2 phosphorylation, dnJak2 had no effect on Src phosphorylation. Together, these observations demonstrate for the first time that the 15-Lox1-15(S)-HETE axis activates EGFR via redox-sensitive manner, which in turn mediates Src-Jak2-STAT3-dependent MCP-1 expression leading to vascular wall remodeling.

Highlights

  • Whereas dominant negative Src blocked Balloon injury (BI)-induced 15-Lox1enhanced Janus kinase 2 (Jak2) phosphorylation, dnJak2 had no effect on Src phosphorylation

  • Because our previous studies have indicated that 15(S)-hydroxyeicosatetraenoic acids (HETEs) activates signal transducer and activator of transcription 3 (STAT3) and it requires the involvement of Src, we asked the question of whether Jak2 has any role in these effects, and if so, is there any cross-talk between these two non-receptor-tyrosine kinases in the activation of STAT3? In this report we show that both the tyrosine kinases interact with each other downstream to epidermal growth factor receptor (EGFR) in mediating 15-lipoxygenase 1 (15-Lox1)– 15(S)-HETE-induced STAT3 activation and monocyte chemoattractant protein-1 (MCP-1) expression in vascular smooth muscle cells (VSMCs) in vitro and in the artery in vivo

  • Our results demonstrate that EGFR gets activated acutely in the artery after injury alone and with adenovirus-mediated expression of 15-Lox1 and mediates the Src-Jak2-STAT3-MCP-1 signaling axis leading to vascular wall remodeling

Read more

Summary

MATERIALS AND METHODS

Reagents—15(S)-HETE (34720) was purchased from Cayman Chemicals (Ann Arbor, MI). Allopurinol (A8003), apocynin (4Ј-hydroxy-3Ј-methoxyacetophenone) (A10809), catalasepolyethylene glycol (C4963), N-acetyl-L-cysteine (NAC). H and I, all the conditions were the same as in panel G, except that cells were treated with and without 15(S)-HETE (0.5 ␮M) for 2 h and either total cellular RNA was isolated and analyzed for MCP-1 and ␤-actin mRNA levels by RT-PCR (H) or media were collected and analyzed for MCP-1 release by ELISA (I). Cells were transduced with Ad-GFP or Ad-dnJak at 40 m.o.i., growth-arrested, and treated with and without 15(S)-HETE (0.5 ␮M) for 2 h, and either total cellular RNA was isolated and analyzed for MCP-1 and ␤-actin mRNA levels by RT-PCR (D, lower panel) or medium was collected and MCP-1 release was measured by ELISA (E, right panel).

C AG1478
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call